Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
about
Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cellsInvestigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone functionOver-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisNovel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth.Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis.Inhibition of tumor growth and angiogenesis by soluble EphB4.Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.Eph receptors and ephrins as targets for cancer therapy.The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of integrin-β8 in prostate cancer cells.Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome.The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival.Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.Eph-dependent cell-cell adhesion and segregation in development and cancer.Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity.The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.Downregulation of EphA7 by hypermethylation in colorectal cancer.Proteins are potent biomarkers to detect colon cancer progression.Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29).Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition.Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.Expression of Eph A4, Eph B2 and Eph B4 receptors in AML.
P2860
Q24794019-D6414746-4AF3-48B0-9812-98C7CF77210DQ24815816-57261AA5-7295-4420-B13E-493F1B9E75D7Q27852191-04030971-3B2C-4A83-9D10-AE7EA7D39A6BQ28218547-9F9AE8E7-B380-4995-A8C2-9EDD0928D704Q33245287-E8C29BB9-B926-493F-BA9E-38CDFC0105C7Q33677805-FFCF4C39-B372-4C22-A083-8F01529B7A8AQ33745300-DD6C6DE8-2845-44A3-8D4F-3A433422F9A5Q33848991-5BF26302-26C1-477C-A790-EDDF41A67869Q34770033-048EAEB1-32A1-4B61-9E58-78ED6560571AQ35221906-92DAF9E9-D5C6-4E0A-9E78-B0AAB60ACAA6Q35370195-CC6676F5-34FF-482A-B6DB-0F456E90E43AQ35606620-BCC61541-2C1E-4D7D-A1F7-F59A77B74C02Q35783568-C51A289D-5FFF-46BB-9E03-15B43DEBB0DDQ36610209-7114BB77-767D-474B-A8D7-5A468DFE93E8Q36950556-8F3D181B-7F1F-4553-9F3D-D45725CC4D6BQ37160698-EC72B93F-8B5E-4C6D-ACE1-D491FA63904EQ37690773-547B8365-2279-4385-A4F6-7DF3F90036C0Q37971902-7CC1EEF8-9008-4E84-8F04-15F7A0CAA69BQ38803278-DDFD051C-0FC9-49BF-914A-BD762FFFE582Q39127472-F6A9765C-B407-4296-B823-DE2F68781739Q39429505-EF0EF98C-3D8E-4369-B966-BF46A00A4F7AQ40399375-B78A1CDB-73FA-4A45-BFD8-474CABBC1C5DQ41456559-93BEEE80-BE3E-474B-9B02-323FACDFB13CQ41821364-837AF774-6EF3-4CB2-8747-33BED5DB34A0Q41828383-3D0230E8-1800-4D10-AB00-49237EEBB10DQ42633983-E49DBE0D-6DF0-4CA8-8EBD-0FCABD0FD099Q43083986-2EA6B77A-6486-480C-BEFD-9B8C571D5428Q52595509-E388C7E5-B517-4821-8126-6853A70665C9Q54211664-3013BEED-B704-42C5-94BD-8BB1555CF898
P2860
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@ast
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@en
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@nl
type
label
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@ast
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@en
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@nl
prefLabel
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@ast
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@en
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@nl
P2093
P2860
P356
P1476
Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
@en
P2093
E L Douglas
J E Hardingham
P J Hewett
S A Stephenson
P2860
P2888
P356
10.1186/1471-2199-2-15
P407
P577
2001-01-01T00:00:00Z
P5875
P6179
1011008806